SCHEMBL5380643

SCHEMBL5380643

C[C@H](c1cc(F)c(N2CC[C@H](N(C(=O)O)C(C)(C)C)C2=O)c(F)c1)N(C)C

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F10 P00742 11/20 0.34
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5371161 1.00 F10 (0.34) F10HDAC8HDAC6
SCHEMBL5371113 0.87 F10 (0.47) F10
SCHEMBL5380004 0.87 F10 (0.47) F10
SCHEMBL5381540 0.83 HDAC8 (0.33) HDAC8HDAC6
SCHEMBL5384027 0.82 HDAC8 (0.32) F10HDAC8HDAC6
SCHEMBL5377448 0.81 HDAC8 (0.40) HDAC8HDAC6
SCHEMBL5380049 0.79 F10 (0.39) F10
SCHEMBL5386312 0.78 F10 (0.39) F10
SCHEMBL5380531 0.77 F10 (0.38) F10
SCHEMBL5379823 0.77 F10 (0.38) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7235544-B2 for use in conjunction with thrombolytic agents, thus permitting the use of a lower dose of thrombolytic agent; treatment of acute vascular diseases; may have potential in neurogenerative diseases such as Parkinson's and Alzheimer's disease GLAXO GROUP LIMITED (GB) 2007-06-26 US disclosed